{
  "$id": "https://www.breakthroughgenerations.org.uk/schemas/NewCancerSummary_PseudoAnon.json",
  "$schema": "https://json-schema.org/draft/2020-12/schema",
  "title": "NewCancerSummary_PseudoAnon",
  "type": "object",
  "properties": {
    "TCode": {
      "type": ["string"],
      "description": "Unique participant identifier",
      "x-description": "Pseudonymised Unique participant identifier in the Generations Study. The field has one to one mapping with STUDY_ID"
    },
    "S_TCode": {
      "type": ["string"],
      "description": "Source from which TCode is selected in the target dataset."
    },
    "TUMOUR_ID": {
      "type": ["number", "null"],
      "description": "Unique identifier for each tumour (one participant may have several).",
      "x-description": "Tumour-specific identifier. A participant may have multiple tumours, each with its own TUMOUR_ID. Provided directly in CancerRegistry.TUMOURID or FlaggingCancers.TumourID. Pathology datasets (HistoPath_BrCa, HistoPath_OvCa) do not include a universal tumour ID, only tumour-level details (e.g., count, site, laterality, size, grade, stage). When integrating, use CancerRegistry.TUMOURID (or FlaggingCancers.TumourID if registry ID is unavailable) as the primary source. The missing values in this field is either not carried from legacy dataset or tumour is from Path report",
      "x-sourcePriority": [
        "CancerRegistry.TUMOURID",
        "FlaggingCancers.TumourID"
      ]
    },
    "S_TUMOUR_ID": {
      "type": ["string", "null"],
      "description": "Source from which the Tumour ID is selected in the target dataset. It will be one of the sources from x-sourcePriority for TUMOUR_ID."
    },
    "DIAGNOSIS_DATE_SHIFTED": {
      "type": ["string", "null"],
      "format": "date-time",
      "description": "Best estimate of tumour diagnosis date (per tumour). The dates are shifted to pseudo-anonymise the PII data"
    },
    "S_DIAGNOSIS_DATE_SHIFTED": {
      "type": ["string"],
      "description": "Source from which shifted Diagnosis Date is selected in the target dataset."
    },
    "DIAGNOSIS_YEAR": {
      "type": ["integer", "null"],
      "description": "Best estimate of tumour diagnosis year (per tumour). Real year from the diagnosis dates",
      "x-description": "Best estimate of tumour diagnosis year calculated separately for each tumour using DIAGNOSIS_DATE"
    },
    "AGE_AT_DIAGNOSIS": {
      "type": ["number"],
      "description": "Age of the patient when they were diagnosed with the tumour in years. (per tumour).",
      "x-description": "Age in whole years at diagnosis, calculated separately for each tumour using DOB from People table and the DIAGNOSIS_DATE for that tumour. Derived as floor((DIAGNOSIS_DATE – DOB) / 365.25).",
      "minimum": 0,
      "maximum": 200
    },
    "ICD_CODE": {
      "type": ["string", "null"],
      "description": "ICD-10-O2 site code (4-character) for tumour site.",
      "x-description": "Primary ICD-10-O2 site code (4-character) describing the site of origin of the neoplasm. Source priority: 1) CancerRegistry.SITE_ICD10_O2 (\"Describes site of origin of the neoplasm\"); 2) FlaggingCancers.CancerICD (\"Cancer ICD code\"). Use the code as provided by the source without recoding. This field is per tumour (TUMOUR_ID). The ICD 9 codes are converted to ICD 10 by referencing https://seer.cancer.gov/tools/conversion/2022/ICD9CM%20to%20ICD10CM.FY2023.11.18.22.pdf (Last access date: 23/10/2025). ICD_CODE is derived in the program for Path data to link tumours across sources",
      "x-sourcePriority": [
        "CancerRegistry.SITE_ICD10_O2",
        "FlaggingCancers.CancerICD",
		    "HistoPath_BrCa.ICD_CODE",
        "HistoPath_OvCa.ICD_CODE"
      ],
      "maxLength": 4
    },
    "S_ICD_CODE": {
      "type": ["string", "null"],
      "description": "Source from which ICD Code is selected in the target dataset. It will be one of the sources from x-sourcePriority for ICD_CODE."
    },
    "MORPH_CODE": {
      "type": ["number", "null"],
      "description": "ICD-O morphology code (tumour histology/behaviour).",
      "x-description": "ICD-O morphology code describing the histological type/behaviour of the tumour (as provided by the source; may include the behaviour suffix, e.g., \"/2\", \"/3\"). Per tumour (TUMOUR_ID). Source priority: 1) CancerRegistry.HISTOLOGY_CODED 2) FlaggingCancers.Histology 3) HistoPath_BrCa.ICDMorphologyCode. Store the code exactly as provided (no recoding). These are renamed to MORPH_CODE to link across sources",
      "x-sourcePriority": [
        "CancerRegistry.MORPH_CODE",
        "FlaggingCancers.MORPH_CODE",
        "HistoPath_BrCa.MORPH_CODE"
      ]
    },
    "S_MORPH_CODE": {
      "type": ["string", "null"],
      "description": "Source from which ICD Morph Code is selected in the target dataset. It will be one of the sources from x-sourcePriority for MORPH_CODE."
    },
    "CANCER_SITE": {
      "type": ["string", "null"],
      "description": "Text description of anatomical site",
      "x-description": "Text description of anatomical site derived using ICD_CODE (ICD 10) as per the IARC standards. The ICD codes are grouped into SITE (e.g., breast and ovarian). Reference link: https://icd.who.int/browse10/2019/en#/II (Last access date: 09/10/2025)"
    },
    "GROUPED_SITE": {
      "type": ["string", "null"],
      "description": "Combined site for cancers as per GLOBOCAN 2020 database",
      "x-description": "The cancers are combined using ICD-10 codes between C00-C97 as per GLOBOCAN 2020 database. Reference link: https://pubmed.ncbi.nlm.nih.gov/33538338/ (Last access date: 17/11/2025). There are 3 additional groups to represent in-situ, benign, and unknown tumours"
    },
    "GRADE": {
      "type": ["string", "null"],
      "description": "Tumour histological grade (harmonised, per registry coding).",
      "x-description": "Tumour histological grade (harmonised to Cancer Registry coding). Source priority: 1) CancerRegistry.GRADE (retain registry codes exactly: GX, G0–G7, GL/GH/GI/G) 2) For breast: HistoPath_BrCa.InvasiveGrade, mapped to Cancer Registry format (InvasiveGrade 1→G1, 2→G2, 3→G3). If InvasiveGrade is null then take DCISGrade (in situ Low, Intermediate and High to be mapped to GL, GI and GH); 3) For ovarian: HistoPath_OvCa.Grade_I_II_III, mapped to Cancer Registry format (I→G1, II→G2, III→G3); All pathology- and registry-derived values must be harmonised into the Cancer Registry coding system; Cancer Registry values take precedence when present.",
      "x-sourcePriority": [
        "CancerRegistry.GRADE",
        "HistoPath_BrCa.InvasiveGrade",
        "HistoPath_BrCa.DCISGrade",
        "HistoPath_OvCa.Grade_I_II_III"        
      ],
      "enum": ["GX", "G0", "G1", "G2", "G3", "G4", "G5", "G6", "G7", "GL", "GH", "GI", "G", null],
      "enumDescriptions": [
        "GX: Grade of differentiation is not appropriate or cannot be assessed",
        "G0: Borderline malignancy",
        "G1: Well differentiated",
        "G2: Moderately differentiated",
        "G3: Poorly differentiated",
        "G4: Undifferentiated / anaplastic",
        "G5: T Cell",
        "G6: B Cell",
        "G7: Null cell",
        "GL: Low",
        "GH: High",
        "GI: Intermediate",
        "G:",
        "null: Missing in the report"
      ]
    },
    "S_GRADE": {
      "type": ["string", "null"],
      "description": "Source from which Grade is selected in the target dataset. It will be one of the sources from x-sourcePriority for GRADE."
    },
    "TUMOUR_SIZE": {
      "type": ["number", "null"],
      "description": "Largest tumour dimension in millimetres.",
      "x-description": "Largest tumour dimension in millimetres (harmonised to Cancer Registry coding). Source priority: 1)CancerRegistry.TUMOURSIZE. Cancer Registry values take precedence when available; record numeric size only, null if text/ambiguous; 2) Pathology: Breast (HistoPath_BrCa.SizeInvasiveTumour; if invasive size missing and DCIS only, use HistoPath_BrCa.SizeDCISOnly).",
      "x-sourcePriority": [
        "CancerRegistry.TUMOURSIZE",
        "HistoPath_BrCa.SizeInvasiveTumour",
        "HistoPath_BrCa.SizeDCISOnly"
      ]
    },
    "S_TUMOUR_SIZE": {
      "type": ["string", "null"],
      "description": "Source from which size of the tumour is selected in the target dataset. It will be one of the sources from x-sourcePriority for TUMOUR_SIZE."
    },
    "NODES_TOTAL": {
      "type": ["integer", "null"],
      "description": "Number of lymph nodes examined.",
      "x-description": "Total number of local/regional lymph nodes examined (per tumour, TUMOUR_ID). Source priority: 1) CancerRegistry.NODESINVOLVED — described in the registry schema as the \"number of local and regional nodes examined.\" Ovarian pathology does not provide node counts. Store as an integer; null if unavailable. 2) Breast pathology: NodesTotal = HistoPath_BrCa.AxillaryNodesTotal + HistoPath_BrCa.OtherNodesTotal (sum; treat nulls as 0 only if at least one component is non-null);",
      "x-sourcePriority": [
        "CancerRegistry.NODESEXCISED",
        "HistoPath_BrCa.NodesTotal"
        ]
    },
    "S_NODES_TOTAL": {
      "type": ["string", "null"],
      "description": "Source from which total nodes are selected in the target dataset. It will be one of the sources from x-sourcePriority for NODES_TOTAL."
    },
    "NODES_POSITIVE": {
      "type": ["integer", "null"],
      "description": "Number of lymph nodes positive for metastasis.",
      "x-description": "Number of local/regional lymph nodes positive for metastasis (per tumour, TUMOUR_ID). Source priority: 1) CancerRegistry.NODESEXCISED — described in the registry schema as the \"number of local and regional nodes reported as being positive.\" Ovarian pathology does not provide node counts. Store as an integer; null if unavailable. 2) Breast pathology: NodesPositive = HistoPath_BrCa.AxillaryNodesPositive + HistoPath_BrCa.OtherNodesPositive (sum; treat nulls as 0 only if at least one component is non-null);",
      "x-sourcePriority": [
        "CancerRegistry.NODESINVOLVED",
        "HistoPath_BrCa.NodesPositive"       
      ]
    },
    "S_NODES_POSITIVE": {
      "type": ["string", "null"],
      "description": "Source from which positive nodes are selected in the target dataset. It will be one of the sources from x-sourcePriority for NODES_POSITIVE."
    },
    "STAGE": {
      "type": ["string", "null"],
      "description": "Best overall tumour stage.",
      "x-description": "Best tumour stage at diagnosis (harmonised to Cancer Registry coding). Source priority: 1) CancerRegistry.STAGE_BEST. Cancer Registry stage takes precedence when available; all values must be expressed in the Cancer Registry coding system.; 2) Pathology staging (Breast: HistoPath_BrCa.Stage, Derived using Tstage, Nstage, Mstage; Ovarian: HistoPath_OvCa.Stage_FIGO), mapped to Cancer Registry stage format;",
      "x-sourcePriority": [
        "CancerRegistry.STAGE_BEST",
        "HistoPath_BrCa.Stage",
        "HistoPath_OvCa.Stage_FIGO"
      ],
      "enum": ["0", "0A", "0B", "0C", "0IS", "1", "1C3", "1A", "1A1", "1A2", "1A3", "1AE", "1AES", "1AEX", "1AEXS", "1AS", "1AX", "1B", "1B1", "1B2", "1BE", "1BES", "1BEX", "1BS", "1BX", "1C", "1C1", "1C2", "IC3", "1E", "1ES", "1EX", "1S", "1X", "1XS", "2", "2A", "2A1", "2A2", "2AE", "2AES", "2AEX", "2AS", "2AX", "2B", "2BE", "2BEX", "2BS", "2BX", "2C", "2E", "2ES", "2EX", "2S", "2X", "3", "3A", "3A1", "3A1i", "3A1ii", "3A2", "3AE", "3AES", "3AEX", "3AS", "3AX", "3B", "3BE", "3BES", "3BEX", "3BEXS", "3BS", "3BX", "3BXS", "3C", "3C1", "3C2", "3D", "3E", "3ES", "3EX", "3S", "3X", "3XS", "4", "4A", "4AE", "4AES", "4AEX", "4AEXS", "4AS", "4AX", "4AXS", "4B", "4BE", "4BES", "4BEX", "4BEXS", "4BS", "4BX", "4BXS", "4BS", "4BX", "4BXS", "4C", "4E", "4ES", "4EX", "4EXS", "4S", "4X", "A", "B", "C", "5", "6", "NA", "?", "U", "X", null],
      "enumDescriptions": [
        "Stage 0: 0, 0A, 0B, 0C, 0IS",
        "Stage 1: 1, 1A, 1A1, 1A2, 1A3, 1AE, 1AES, 1AEX, 1AEXS, 1AS, 1AX, 1B, 1B1, 1B2, 1BE, 1BES, 1BEX, 1BS, 1BX, 1C, 1C1, 1C2, IC3, 1E, 1ES, 1EX, 1S, 1X, 1XS",
        "Stage 2: 2, 2A, 2A1, 2A2, 2AE, 2AES, 2AEX, 2AS, 2AX, 2B, 2BE, 2BEX, 2BS, 2BX, 2C, 2E, 2ES, 2EX, 2S, 2X",
        "Stage 3: 3, 3A, 3A1, 3A1i, 3A1ii, 3A2, 3AE, 3AES, 3AEX, 3AS, 3AX, 3B, 3BE, 3BES, 3BEX, 3BEXS, 3BS, 3BX, 3BXS, 3C, 3C1, 3C2, 3D,  3E, 3ES, 3EX, 3S, 3X, 3XS",
        "Stage 4: 4, 4A, 4AE, 4AES, 4AEX, 4AEXS, 4AS, 4AX, 4AXS, 4B, 4BE, 4BES, 4BEX, 4BEXS, 4BS, 4BX, 4BXS, 4BS, 4BX, 4BXS, 4C, 4E, 4ES, 4EX, 4EXS, 4S, 4X",
        "A, B, C: RaiBinet stage",
        "5: Outdated or invalid code",
        "6: not stageable",
        "NA/?: insufficient information",
        "U: unstageable",
        "X: not staged",
        "null: Missing in the report"
      ]
    },
    "S_STAGE": {
      "type": ["string", "null"],
      "description": "Source from which Stage is selected in the target dataset. It will be one of the sources from x-sourcePriority for STAGE."
    },
    "ER_STATUS": {
      "type": ["string", "null"],
      "description": "Oestrogen receptor status (breast tumours only).",
      "x-description": "Oestrogen receptor (ER) status (harmonised to Cancer Registry coding). Source priority: 1) CancerRegistry.ER_STATUS (retain registry codes: P/N/B/X/U). Cancer Registry values take precedence when available; all values must be expressed in the Cancer Registry coding system. 2) HistoPath_BrCa.ER_Status (map NP → X; retain P/N; map borderline if present to B);",
      "x-sourcePriority": [
        "CancerRegistry.ER_STATUS",
        "HistoPath_BrCa.ER_Status"
      ],
      "enum": ["N", "P", "X", "B", "U", null],
      "enumDescriptions": ["N: Negative", "P: Positive", "X: Not Performed", "B: Borderline", "U:", "null: Not applicable"]
    },
    "S_ER_STATUS": {
      "type": ["string", "null"],
      "description": "Source from which ER Status is selected in the target dataset. It will be one of the sources from x-sourcePriority for ER_STATUS."
    },
    "PR_STATUS": {
      "type": ["string", "null"],
      "description": "Progesterone receptor status (breast tumours only).",
      "x-description": "Progesterone receptor (PR) status (harmonised to Cancer Registry coding). Source priority: 1) CancerRegistry.PR_STATUS (retain registry codes: P/N/B/X/U). Cancer Registry values take precedence when available; all values must be expressed in the Cancer Registry coding system. 2) HistoPath_BrCa.PR_Status (map NP → X; retain P/N; map borderline if present to B);",
      "x-sourcePriority": [
        "CancerRegistry.PR_STATUS",
        "HistoPath_BrCa.PR_Status"
      ],
      "enum": ["N", "P", "X", "B", "U", null],
      "enumDescriptions": ["N: Negative", "P: Positive", "X: Not Performed", "B : Borderline", "U: ", "null: Not applicable"]
    },
    "S_PR_STATUS": {
      "type": ["string", "null"],
      "description": "Source from which PR Status is selected in the target dataset. It will be one of the sources from x-sourcePriority for PR_STATUS."
    },
    "HER2_STATUS": {
      "type": ["string", "null"],
      "description": "HER2 receptor status (breast tumours only).",
      "x-description": "HER2 receptor status (harmonised to Cancer Registry coding). Source priority: 1) CancerRegistry.HER2_STATUS (retain registry codes: P/N/B/X/U). If both IHC and FISH are available in pathology, use the definitive integrated result; Cancer Registry values take precedence when available; all values must be expressed in the Cancer Registry coding system. 2) HistoPath_BrCa.HER2_Status (map NP → X; retain P/N/B);",
      "x-sourcePriority": [
        "CancerRegistry.HER2_STATUS",
        "HistoPath_BrCa.HER2_Status"
      ],
      "enum": ["N", "P", "X", "B", "U", null],
      "enumDescriptions": ["N: Negative", "P: Positive", "X: Not Performed", "B: Borderline", "U:", "null: Not applicable"]
    },
    "S_HER2_STATUS": {
      "type": ["string", "null"],
      "description": "Source from which HER2 Status is selected in the target dataset. It will be one of the sources from x-sourcePriority for HER2_STATUS."
    },
    "HER2_FISH": {
      "description": "Fluorescence in situ hybridisation test for HER2 as reported in Histopathology report",
      "type": ["string", "null"],
      "x-description": "Fluorescence in situ hybridisation test for HER2 as reported in Histopathology report. Take the value from path report for Breast cancer using HER_FISH",
      "x-sourcePriority": [
        "HistoPath_BrCa.HER2_FISH"
      ],
      "enum": ["A", "N", "POS", "NEG", "NP", null],
      "enumDescriptions": [
        "A: if the HER2 FISH/ISH test result/significance is described as Amplified in the report.",
        "N: if the HER2 FISH/ISH test result/significance is described as Non-Amplified in the report.",
        "POS: if the HER2 FISH/ISH test result/significance is described as Positive in the report.",
        "NEG: if the HER2 FISH/ISH test result/significance is described as Negative or Normal in the report.",
        "NP: if the HER2 FISH/ISH test is explicitly specified as Not Performed in the report",
        "null: if the HER2 FISH/ISH test result is not present in the report, if the FISH/ISH test is requested but no FISH/ISH test results are present in this report, and if the report mentions that the FISH/ISH test is not applicable (N/A) to the patient."
      ]
    },
    "Ki67": {
      "type": ["number", "null"],
      "description": "Ki67 proliferation index (% positive nuclei, breast only).",
      "x-description": "Ki67 proliferation index (% of tumour nuclei positive, recorded as an integer 1–100). Source: HistoPath_BrCa.Ki67 only. Pathology values are stored as-is; record as a numeric percentage without the % sign. Null if not reported. Each value is per tumour (TUMOUR_ID).",
      "x-sourcePriority": [
        "HistoPath_BrCa.Ki67"
      ],
      "minimum": 1,
      "maximum": 100
    },
    "SCREEN_DETECTED": {
      "type": ["string", "null"],
      "description": "Whether tumour was screen-detected (Y/N/8/9).",
      "x-description": "Whether the tumour was detected via a screening programme. Source priority: 1) CancerRegistry.SCREENDETECTED. 2) HistoPath_BrCa.ScreenDetected (Y/N/NK → map NK to '9'). Allowed values: 'Y' (Yes), 'N' (No), '8' (Not applicable), '9' (Not known).",
      "x-sourcePriority": [
        "CancerRegistry.SCREENDETECTED",
        "HistoPath_BrCa.ScreenDetected"
      ],
      "enum": ["N", "Y", "8", "9", null],
      "enumDescriptions": ["N : No", "Y : Yes", "8 : Not applicable", "9 : Not known", "null: missing"]
    },
    "S_SCREEN_DETECTED": {
      "type": ["string", "null"],
      "description": "Source from which screen detection value is selected in the target dataset. It will be one of the sources from x-sourcePriority for SCREEN_DETECTED."
    },
    "SCREENINGSTATUSCOSD_CODE": {
      "description": "Screening status code of the tumour",
      "type": ["string", "null"],
      "x-description": "Screening status code of the tumour from Cancer Registry using SCREENINGSTATUSCOSD_CODE",
      "x-sourcePriority": [
        "CancerRegistry.SCREENINGSTATUSCOSD_CODE"
      ],
      "enum": ["1", "2", "4", "5", "6", "7", "9", "NM", null],
      "enumDescriptions": [
        "1 : Screen-detected",
        "2 : Interval Cancer",
        "4 : Lapsed Attender",
        "5 : Never Attended",
        "6 : Never Invited",
        "7 : Other",
        "9 : Not Known",
        "NM : Not Mapped",
        "null: missing"
      ]
    },
    "SCREENINGSTATUSFULL_CODE": {
      "description": "Large number of codes used to detail screening status.",
      "type": ["string", "null"],
      "x-description": "Full detailed screening status of the tumour code from Cancer Registry using SCREENINGSTATUSFULL_CODE",
      "x-sourcePriority": [
        "CancerRegistry.SCREENINGSTATUSFULL_CODE"
      ]
    },
    "LATERALITY": {
      "type": ["string", "null"],
      "description": "Side of body affected (left, right, bilateral, unknown).",
      "x-description": "Laterality of the tumour (per tumour, TUMOUR_ID). Source priority: 1) CancerRegistry.LATERALITY (retain registry codes: L, R, M, B, 8, 9). Cancer Registry values take precedence when available; harmonise all values to registry coding. 2) HistoPath_BrCa.Side (map L/R as-is, U → '9'). These are renamed to LATERALITY link across sources",
      "x-sourcePriority": [
        "CancerRegistry.LATERALITY",
        "HistoPath_BrCa.LATERALITY"        
      ],
      "enum": ["L", "R", "M", "B", "8", "9", null],
      "enumDescriptions": ["L: Left", "R: Right", "M: Midline", "B: Bilateral", "8: Not applicable", "9: Not Known", "null: Missing"]
    },
    "S_LATERALITY": {
      "type": ["string", "null"],
      "description": "Source from which laterality of the tumour is selected in the target dataset. It will be one of the sources from x-sourcePriority for LATERALITY."
    },
    "T_STAGE": {
      "type": ["string", "null"],
      "description": "TNM T component (tumor size).",
      "x-description": "Tumour TNM T stage (per tumour, TUMOUR_ID). Source priority: 1) CancerRegistry.T_BEST. 2) HistoPath_BrCa.Tstage; Cancer Registry values take precedence when available; harmonise to Cancer Registry coding.",
      "x-sourcePriority": [
        "CancerRegistry.T_BEST",
        "HistoPath_BrCa.Tstage"        
      ]
    },
    "S_T_STAGE": {
      "type": ["string", "null"],
      "description": "Source from which T Stage of the tumour is selected in the target dataset. It will be one of the sources from x-sourcePriority for T_STAGE."
    },
    "N_STAGE": {
      "type": ["string", "null"],
      "description": "TNM N component (lymph node involvement).",
      "x-description": "Tumour TNM N stage (per tumour, TUMOUR_ID). Source priority: 1) CancerRegistry.N_BEST. 2)HistoPath_BrCa.NStage; Cancer Registry values take precedence when available; harmonise to Cancer Registry coding. For ovarian cancers, use STAGE rather than TNM.",
      "x-sourcePriority": [
        "CancerRegistry.N_BEST",
        "HistoPath_BrCa.NStage"        
      ]
    },
    "S_N_STAGE": {
      "type": ["string", "null"],
      "description": "Source from which N Stage of the tumour is selected in the target dataset. It will be one of the sources from x-sourcePriority for N_STAGE."
    },
    "M_STAGE": {
      "type": ["string", "null"],
      "description": "TNM M component (distal metastasis)",
      "x-description": "Tumour TNM M stage (per tumour, TUMOUR_ID). Source priority: 1) CancerRegistry.M_BEST. 2) HistoPath_BrCa.Mstage; Cancer Registry values take precedence when available; harmonise to Cancer Registry coding. For ovarian cancers, use STAGE rather than TNM.",
      "x-sourcePriority": [
        "CancerRegistry.M_BEST",
        "HistoPath_BrCa.MStage"        
      ]
    },
    "S_M_STAGE": {
      "type": ["string", "null"],
      "description": "Source from which M Stage of the tumour is selected in the target dataset. It will be one of the sources from x-sourcePriority for M_STAGE."
    },
	"REPORT_COUNT": {
      "type": ["integer", "null"],
	  "description": "Pathology Report identifier coded sequentially from 1 to max number of pathology reports per individual",
      "x-description": "This field is carried to final dataset to match the tissue blocks received as part of pathology process. ",
      "x-sourcePriority": [
        "HistoPath_BrCa.ReportCount"        
      ]
    },
	"TUMOUR_COUNT": {
      "type": ["integer", "null"],
	  "description": "Tumour identifier coded sequencially from 1 to max number of tumours per pathology report. Dataset has one row per tumour, eg a patient with 2 tumours will have 2 rows with TumourCount=1 and TumourCount=2. No missing values allowed",
      "x-description": "This field is carried to final dataset to match the tissue blocks received as part of pathology process. ",
      "x-sourcePriority": [
        "HistoPath_BrCa.TumourCount"        
      ]
    },
    "CREATED_TIME": {
      "type": ["string"],
      "format": "date-time",
      "description": "Time when cancer summary record was created.",
      "x-description": "Timestamp (YYYY-MM-DD or date-time) when this cancer summary record was created. Set by the integration process; not sourced from clinical data.",
      "x-sourcePriority": []
    },
    "COMMENTS": {
      "type": ["string", "null"],
      "description": "Free-text notes about tumour record.",
      "x-description": "Free-text notes about data integration decisions or anomalies for this tumour record.",
      "x-sourcePriority": []
    }
  }
}